Sienna Gestion’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.02M Sell
152,317
-11,871
-7% -$682K 0.53% 66
2026
Q1
$9.88M Hold
164,188
0.64% 57
2025
Q4
$8.86M Hold
164,188
0.53% 65
2025
Q3
$6.75M Hold
164,188
0.47% 75
2025
Q2
$6.94M Buy
164,188
+14,408
+10% +$707K 0.48% 78
2025
Q1
$8.88M Sell
149,780
-8,519
-5% -$497K 0.72% 46
2024
Q4
$8.95M Buy
158,299
+139,048
+722% +$7.77M 0.6% 49
2024
Q3
$994K Buy
+19,251
New +$903K 0.07% 129

Other funds holding BMY

Sienna Gestion's BMY Position: Q2 2026 in Review

Sienna Gestion reduced its Bristol-Myers Squibb (BMY) stake by 7.2% in Q2 2026, selling an estimated $682K and leaving 152,317 shares worth $9.02M. The position accounts for 0.53% of the portfolio, ranked #66.

Sienna Gestion first reported a position in BMY in Q3 2024 and has held it in 8 quarters since. The position peaked at $9.88M in Q1 2026. 2,524 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Sienna Gestion held 152,317 shares of Bristol-Myers Squibb worth $9.02M as of Q2 2026.
  • Sienna Gestion sold 11,871 Bristol-Myers Squibb shares in Q2 2026, an estimated $682K.
  • Bristol-Myers Squibb made up 0.53% of Sienna Gestion's portfolio in Q2 2026, its #66 holding.
  • Sienna Gestion first reported a position in Bristol-Myers Squibb in Q3 2024 and has held it in 8 quarters since.
  • Sienna Gestion's Bristol-Myers Squibb position peaked at $9.88M in Q1 2026.
  • 2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Sienna Gestion's 13F filing for Q2 2026, filed 13 Aug 2026.